MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Single-photon emission computed tomography(SPECT)"

  • 2024 International Congress

    Impact of Striatal Degeneration on Patient Reported Symptoms in Idiopathic Normal Pressure Hydrocephalus

    Q. Hu, K. Badiola-Lim, D. Karimeddini, C-L. Kuo, N. Prakash (Farmington, USA)

    Objective: To compare the subjective presenting motor (MS) and nonmotor symptoms (NMS) in subjects with idiopathic normal pressure hydrocephalus (iNPH) with and without striatal degeneration…
  • 2024 International Congress

    Impact of Striatal Degeneration on Clinical Phenotype in Idiopathic Normal Pressure Hydrocephalus: A Comparative Analysis

    K. Badiola-Lim, Q. Hu, N. Prakash (Summit, USA)

    Objective: To compare the clinical phenotype between patients with normal and abnormal dopamine transporter scan (DaTscan) in probable and definite idiopathic normal pressure hydrocephalus (iNPH).…
  • 2024 International Congress

    The relationship between pain threshold and striatal dopamine function in Parkinson’s Disease

    H. Kawasaki, Y. Sakasai, S. Fujita, R. Yokoyama, K. Seo, Y. Ito, T. Yamamoto (moroyama, Japan)

    Objective: This study aims to determine the relationship between pain threshold and striatal dopamine function in people with Parkinson's disease. Background: About 40-85% of Parkinson's…
  • 2023 International Congress

    Brain first-body first: is the dat-scan useful?

    G. Bellini, G. Palermo, D. Frosini, E. Benevento, E. Del Prete, M G. Tedeschi, S. Visinoni, A. Francesconi, R. Ceravolo (Pisa, Italy)

    Objective: The purpose of this study is to evaluate possible differences in the DAT-SCAN ratios in patients with and without dysautonomia and RBD at diagnosis.…
  • 2023 International Congress

    Correlation between Striatal degeneration and Cerebellar fiber alterations of Parkinson’s disease

    A. Shindo, T. Ogawa, T. Hatano, S. Ueno, W. Sako, K. Kamagata, A. Christina, H. Amano-Takeshige, W. Uchida, G. Oyama, A. Umemura, H. Iwamuro, M. Ito, A. Nakanishi, K. Murakami, S. Aoki, N. Hattori (Bunkyo-ku, Tokyo, Japan)

    Objective: We tried to show divisional evaluation of caudate and putamen in [123I] FP-CIT(DAT) -SPECT has use for assessment of PD symptoms and capture the…
  • 2023 International Congress

    Radiological markers of CSF α-synuclein aggregation in Parkinson’s disease patients

    A. Droby, A. Yoffe-Vasiliev, K. Fraser, O. Mabrouk, B. Cohen, N. Omer, A. Bar Shira, M. Gana-Weisz, O. Goldstein, R. Alcalay, A. Orr-Urtreger, J. Shirvan, J. Cedarbaum, N. Giladi, A. Mirelman, A. Thaler (Tel-Aviv, Israel)

    Objective: To investigate the association between cerebrospinal (CSF) αS aggregates, MRI, and dopamine transporter spectral tomography (DaTscanTM) imaging metrics. Background: Synuclein amplification assays (SAA) enables…
  • 2023 International Congress

    Genetic polymorphisms associated with nigrostriatal dopaminergic depletion as measured with [I123]-FP-CIT SPECT in Parkinson’s disease

    S. Castro Labrador, MA. Labrador Espinosa, J. Silva Rodríguez, D. García Solís, P. Mir, MJ. Grothe (Seville, Spain)

    Objective: To conduct a genome-wide association study (GWAS) of striatal [I123]-FP-CIT SPECT signal as endophenotype to explore possible associations between genetic background and nigrostriatal dopaminergic…
  • 2023 International Congress

    An in-vivo study of the integrity of the nigrostriatal pathways in drug-naive Parkinson’s disease patients using [11C]PE2I PET and neuromelanin-Magnetic Resonance Imaging

    G. Pagano, H. Wilson, E. de Natale, F. Niccolini, S. Polychronis, T. Yousaf, R. Gunn, E. Rabiner, M. Mehta, M. Politis (Basel, Switzerland)

    Objective: This study evaluated the relationship between the neurodegeneration of the substantia nigra neurons, assessed using Neuromelanin-sensitive MRI, and of the loss of striatal dopaminergic…
  • 2023 International Congress

    Insular dopamine deficits in prodromal α-synucleinopathies

    A. Galli, A. Pilotto, C. Zatti, F. Placidi, F. Izzi, E. Premi, A. Rizzardi, M. Catania, A. Lupini, L. Purin, M. Pasolini, N. Mercuri, A. Chiaravalloti, M. Fernandes, C. Calvello, B. Paghera, D. Berg, A. Padovani, C. Liguori (Brescia, Italy)

    Objective: aim of the study was to evaluate the dopamine binding characterizing subjects both at prodromal and symptomatic stages in α-synucleinopathies, by means of ROI-based…
  • 2023 International Congress

    Education and the motor effects of dopamine loss in Parkinson’s disease

    M. Hoenig, V. Dzialas, M. Banwinkler, A. Asendorf, T. van Eimeren (Juelich, Germany)

    Objective: To examine the relation between education and dopamine signal loss in PD. Background: In support of the cognitive reserve concept, it has consistently been…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley